These authors found that the prostate cancer outlier lncRNA PCAT-1 can regulate the cellular response to genotoxins by repressing the expression of BRCA2 to create a deficiency in homologous recombination (HR). The gene discussed is BRCA2; the disease is Familial prostate cancer.